Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Pharmaxis unveils commercial launch of Bronchitol® (mannitol) as add‐on maintenance therapy for cystic fibrosis in the US

% of readers think this story is Fact. Add your two cents.


Pharmaxis Ltd’s (ASX:PXS) (OTCMKTS:PXSLY) (FRA:UUD) exclusive US distributor, Chiesi USA Inc, has launched Bronchitol®  (mannitol), an add‐on maintenance therapy to improve pulmonary function in cystic fibrosis (CF)  patients aged 18 years and older in the US.

Bronchitol, developed by Pharmaxis, is the first dry powder inhaled mucoactive agent providing a compact, portable treatment option for CF patients.

Cash flow positive from FY2021

Pharmaxis chief executive officer Gary Phillips said: “We expect Bronchitol sales in the US to contribute strongly to the product’s global sales and profit growth, making the Pharmaxis mannitol respiratory business cash flow positive from FY 2021.”

The company has so far received a total of US$10 million in Bronchitol milestone payments from Chiesi, triggered by the US Food and Drugs Administration (FDA) approval in October 2020 and the recent first shipment of stock to the US.

Phase 3 trial published

Chiesi also reveals that data from the Pharmaxis Phase 3 global clinical trial (CF303) evaluating the efficacy and safety of Bronchitol in adults with CF has been published online in the Journal of Cystic Fibrosis.

Bronchitol

Bronchitol is manufactured and exported from the Pharmaxis manufacturing facility in Sydney. The product is marketed in Europe, Russia and several other countries and is PBS listed for the treatment of Australian adults and children.

CF is a debilitating genetic disease that causes progressive damage to the lungs and other organs.

Chiesi

Chiesi is responsible for the commercialisation of Bronchitol in the US.

Bronchitol joins Pharmaxis’ first commercial product, Aridol®, in being FDA‐approved.

Aridol is a lung function test designed to help doctors diagnose and manage asthma by detecting active airway inflammation.

Story by ProactiveInvestors



Source: http://www.proactiveinvestors.com/companies/news/944315/pharmaxis-unveils-commercial-launch-of-bronchitol-mannitol-as-addon-maintenance-therapy-for-cystic-fibrosis-in-the-us-944315.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!


Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST


Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.

Report abuse
Loading...

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.